Tissue and urokinase plasminogen activators in the environs of venous and ischaemic leg ulcers. 1993

M C Stacey, and K G Burnand, and M Mahmoud-Alexandroni, and P J Gaffney, and B S Bhogal
Department of Surgery, St Thomas' Hospital, London, UK.

Urokinase plasminogen activator (uPA) and tissue plasminogen activator (tPA) were assayed in biopsies from the base, edge and adjacent skin of ischaemic and venous ulcers using a functional bioimmunoassay and a standard immunoassay. Two series of 14 biopsies were examined: from seven venous and seven ischaemic ulcers in the first series, eight venous and six ischaemic in the second. It was found that tPA was detected in only four samples of ulcer edge using the bioimmunoassay and in no sample by the standard immunoassay. By contrast, uPA was detected in all but one ulcer edge biopsy and at a significantly lower median concentration in the adjacent skin (16.9 units/g) than the ulcer edge (26.1 units/g) or base (32.3 units/g) (both P < 0.01). Levels of uPA were greater in the edge and base of venous compared with ischaemic ulcers. The predominant plasminogen activator in chronic leg ulcers is uPA; this activator may play an important role in wound healing.

UI MeSH Term Description Entries
D007511 Ischemia A hypoperfusion of the BLOOD through an organ or tissue caused by a PATHOLOGIC CONSTRICTION or obstruction of its BLOOD VESSELS, or an absence of BLOOD CIRCULATION. Ischemias
D007866 Leg The inferior part of the lower extremity between the KNEE and the ANKLE. Legs
D007871 Leg Ulcer Ulceration of the skin and underlying structures of the lower extremity. About 90% of the cases are due to venous insufficiency (VARICOSE ULCER), 5% to arterial disease, and the remaining 5% to other causes. Leg Ulcers,Ulcer, Leg,Ulcers, Leg
D010959 Tissue Plasminogen Activator A proteolytic enzyme in the serine protease family found in many tissues which converts PLASMINOGEN to FIBRINOLYSIN. It has fibrin-binding activity and is immunologically different from UROKINASE-TYPE PLASMINOGEN ACTIVATOR. The primary sequence, composed of 527 amino acids, is identical in both the naturally occurring and synthetic proteases. Alteplase,Plasminogen Activator, Tissue-Type,T-Plasminogen Activator,Tissue-Type Plasminogen Activator,Actilyse,Activase,Lysatec rt-PA,TTPA,Tisokinase,Tissue Activator D-44,Lysatec rt PA,Lysatec rtPA,Plasminogen Activator, Tissue,Plasminogen Activator, Tissue Type,T Plasminogen Activator,Tissue Activator D 44,Tissue Type Plasminogen Activator
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012867 Skin The outer covering of the body that protects it from the environment. It is composed of the DERMIS and the EPIDERMIS.
D014568 Urokinase-Type Plasminogen Activator A proteolytic enzyme that converts PLASMINOGEN to FIBRINOLYSIN where the preferential cleavage is between ARGININE and VALINE. It was isolated originally from human URINE, but is found in most tissues of most VERTEBRATES. Plasminogen Activator, Urokinase-Type,U-Plasminogen Activator,Urinary Plasminogen Activator,Urokinase,Abbokinase,Kidney Plasminogen Activator,Renokinase,Single-Chain Urokinase-Type Plasminogen Activator,U-PA,Single Chain Urokinase Type Plasminogen Activator,U Plasminogen Activator,Urokinase Type Plasminogen Activator
D014647 Varicose Ulcer Skin breakdown or ulceration in the drainage area of a VARICOSE VEIN, usually in the leg. Stasis Ulcer,Venous Ulcer,Venous Hypertension Ulcers,Venous Stasis Ulcers,Hypertension Ulcer, Venous,Hypertension Ulcers, Venous,Stasis Ulcer, Venous,Stasis Ulcers,Stasis Ulcers, Venous,Ulcer, Stasis,Ulcer, Varicose,Ulcer, Venous,Ulcer, Venous Hypertension,Ulcer, Venous Stasis,Ulcers, Stasis,Ulcers, Varicose,Ulcers, Venous,Ulcers, Venous Hypertension,Ulcers, Venous Stasis,Varicose Ulcers,Venous Hypertension Ulcer,Venous Stasis Ulcer,Venous Ulcers

Related Publications

M C Stacey, and K G Burnand, and M Mahmoud-Alexandroni, and P J Gaffney, and B S Bhogal
October 1995, International journal of dermatology,
M C Stacey, and K G Burnand, and M Mahmoud-Alexandroni, and P J Gaffney, and B S Bhogal
May 1999, VASA. Zeitschrift fur Gefasskrankheiten,
M C Stacey, and K G Burnand, and M Mahmoud-Alexandroni, and P J Gaffney, and B S Bhogal
November 2000, The British journal of dermatology,
M C Stacey, and K G Burnand, and M Mahmoud-Alexandroni, and P J Gaffney, and B S Bhogal
March 1990, Experimental cell research,
M C Stacey, and K G Burnand, and M Mahmoud-Alexandroni, and P J Gaffney, and B S Bhogal
January 1991, Biochemical and biophysical research communications,
M C Stacey, and K G Burnand, and M Mahmoud-Alexandroni, and P J Gaffney, and B S Bhogal
April 1994, Oral surgery, oral medicine, and oral pathology,
M C Stacey, and K G Burnand, and M Mahmoud-Alexandroni, and P J Gaffney, and B S Bhogal
April 2015, Journal of vascular surgery. Venous and lymphatic disorders,
M C Stacey, and K G Burnand, and M Mahmoud-Alexandroni, and P J Gaffney, and B S Bhogal
January 1987, The Journal of investigative dermatology,
M C Stacey, and K G Burnand, and M Mahmoud-Alexandroni, and P J Gaffney, and B S Bhogal
November 1993, Archives of biochemistry and biophysics,
M C Stacey, and K G Burnand, and M Mahmoud-Alexandroni, and P J Gaffney, and B S Bhogal
October 1991, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research,
Copied contents to your clipboard!